| Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer JC Soria, Y Ohe, J Vansteenkiste, T Reungwetwattana, B Chewaskulyong, ... New England journal of medicine 378 (2), 113-125, 2018 | 4391 | 2018 |
| Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation JK Litton, HS Rugo, J Ettl, SA Hurvitz, A Gonçalves, KH Lee, ... New England Journal of Medicine 379 (8), 753-763, 2018 | 1806 | 2018 |
| Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open … A Wang-Gillam, CP Li, G Bodoky, A Dean, YS Shan, G Jameson, ... The Lancet 387 (10018), 545-557, 2016 | 1163 | 2016 |
| Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized … JY Jang, Y Han, H Lee, SW Kim, W Kwon, KH Lee, DY Oh, EK Chie, ... Annals of surgery 268 (2), 215-222, 2018 | 592 | 2018 |
| Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study MS Lee, BY Ryoo, CH Hsu, K Numata, S Stein, W Verret, SP Hack, ... The Lancet Oncology 21 (6), 808-820, 2020 | 427 | 2020 |
| Optimization of patient selection for gefitinib in non–small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt … SW Han, TY Kim, YK Jeon, PG Hwang, SA Im, KH Lee, JH Kim, DW Kim, ... Clinical Cancer Research 12 (8), 2538-2544, 2006 | 330 | 2006 |
| Studies on the mechanism of action of salicylate II. Retardation of wound healing by aspirin KH Lee Journal of Pharmaceutical Sciences 57 (6), 1042-1043, 1968 | 330 | 1968 |
| Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis B Keam, SA Im, KH Lee, SW Han, DY Oh, JH Kim, SH Lee, W Han, ... Breast Cancer Research 13, 1-7, 2011 | 297 | 2011 |
| Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial JK Litton, SA Hurvitz, LA Mina, HS Rugo, KH Lee, A Gonçalves, S Diab, ... Annals of Oncology 31 (11), 1526-1535, 2020 | 266 | 2020 |
| Anti-inflammatory activity of sesquiterpene lactones and related compounds IH Hall, KH Lee, CO Starnes, Y Sumida, RY Wu, TG Waddell, JW Cochran, ... Journal of Pharmaceutical Sciences 68 (5), 537-542, 1979 | 255 | 1979 |
| Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index Y Choi, DY Oh, TY Kim, KH Lee, SW Han, SA Im, TY Kim, YJ Bang PloS one 10 (10), e0139749, 2015 | 246 | 2015 |
| Major clinical research advances in gynecologic cancer in 2011 DH Suh, K Kim, JW Kim Journal of gynecologic oncology 23 (1), 53, 2012 | 236* | 2012 |
| Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer SW Han, DY Oh, SA Im, SR Park, KW Lee, HS Song, NS Lee, KH Lee, ... British Journal of Cancer 100 (2), 298-304, 2009 | 208 | 2009 |
| A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer JL Lee, YK Kang, HJ Kang, KH Lee, DY Zang, BY Ryoo, JG Kim, SR Park, ... British journal of cancer 99 (4), 584-590, 2008 | 203 | 2008 |
| Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 … DY Oh, KH Lee, DW Lee, J Yoon, TY Kim, JH Bang, AR Nam, KS Oh, ... The Lancet Gastroenterology & Hepatology 7 (6), 522-532, 2022 | 187 | 2022 |
| Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple … A Min, SA Im, DK Kim, SH Song, HJ Kim, KH Lee, TY Kim, SW Han, ... Breast Cancer Research 17, 1-13, 2015 | 176 | 2015 |
| Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing SW Han, HP Kim, JY Shin, EG Jeong, WC Lee, KH Lee, JK Won, TY Kim, ... PloS one 8 (5), e64271, 2013 | 175 | 2013 |
| Mode of action of sesquiterpene lactones as anti-inflammatory agents IH Hall, CO Starnes Jr, KH Lee, TG Waddell Journal of pharmaceutical sciences 69 (5), 537-543, 1980 | 174 | 1980 |
| Studies on the mechanism of action of salicylates III. Effect of vitamin A on the wound healing retardation action of aspirin KH Lee Journal of Pharmaceutical Sciences 57 (7), 1238-1240, 1968 | 156 | 1968 |
| Safety and clinical activity of durvalumab monotherapy in patients with hepatocellular carcinoma (HCC). ZA Wainberg, NH Segal, D Jaeger, KH Lee, J Marshall, SJ Antonia, ... Journal of Clinical Oncology 35 (15_suppl), 4071-4071, 2017 | 152 | 2017 |
